Singapore markets closed

Spago Nanomedical AB (publ) (7UX.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.0236+0.0006 (+2.61%)
At close: 03:29PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-34,413
-42,223
-39,197
-39,071
-18,928
-
Depreciation & amortisation
-
281
356
376
362
-
Change in working capital
-4,843
-3,158
654
3,126
-200
-
Other working capital
-38,960
-45,415
-42,016
-40,196
-25,150
-
Net cash provided by operating activities
-38,454
-44,909
-38,187
-35,569
-18,766
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-506
-3,829
-4,627
-6,384
-
Other investing activities
-
-
-
-
1
-
Net cash used for investing activities
-565
-506
-3,829
-4,627
-6,383
-
Net change in cash
-12,856
-16,884
9,641
24,012
16,299
-
Cash at beginning of period
45,106
62,101
52,460
28,448
12,149
-
Cash at end of period
32,249
45,217
62,101
52,460
28,448
-
Free cash flow
Operating cash flow
-38,454
-44,909
-38,187
-35,569
-18,766
-
Capital expenditure
-
-506
-3,829
-4,627
-6,384
-
Free cash flow
-38,960
-45,415
-42,016
-40,196
-25,150
-